Dr Reddy’s Laboratories on Thursday said it has launched Methylphenidate Hydrochloride extended-release tablets, used to treat attention deficit disorder (ADD), in the US market.
The company’s product is generic version of Janssen Pharmaceuticals’ Concerta tablets, Dr Reddy’s Laboratories said in a statement. The company’s product is generic version of Janssen Pharmaceuticals’ Concerta tablets, Dr Reddy’s Laboratories said in a statement.
According to IQVIA Health, the Concerta brand and generic products had US sales of around USD 1.159 billion for the most recent 12 months ending in June 2020.
The Hyderabad-based firm said its product is available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100. The Hyderabad-based firm said its product is available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
